ACME Solar Q1 FY27 total revenue INR 954 Cr, EBITDA INR 831 Cr, PAT INR 235 Cr
ACME Solar Holdings · Power
Key highlights
- Commissioned ~2.3 GWh BESS till date in Q1 FY27; cumulative commissioned BESS capacity ~3.62 GWh
- Signed 600 MW PPAs with SECI: 300 MW ACME Renewtech Sixth FDRE at INR 6.28/unit and 300 MW Fifth Hybrid at INR 3.25/unit; UC PPA portfolio 3,880 MW
- Debt tie-up of over INR 6,000+ Cr for 700 MW under-construction FDRE projects with REC and PFC; ICRA AA- assigned to operational 300 MW Acme Heergarh
Why it's rated major development: the year-on-year change is 80% (50% or more)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from ACME Solar Holdings
- Capex / expansionNotableACME Solar commissions additional 66.68 MW solar capacity in Rajasthan
- Capex / expansionNotableACME Solar commissions 66.68 MW solar component of Hybrid Power Project
- Order winNotableACME Solar Holdings executes 400 MW Power Purchase Agreement with NTPC
- Capex / expansionMajor developmentACME Solar Holdings reports Q2 FY27 EBITDA ₹874 Cr, PAT ₹269 Cr on consolidated basis
- Capex / expansionNotableACME Solar commissions additional 35.77 MW/143.08 MWh BESS in Rajasthan
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Power
on management's own guidance
- 2
- Strong growth1
- Adani PowerGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.